https://www.taxtmi.com/news?id=22794 The Competition Commission of India approved under Section 31(1) the acquisition by Canary Investments Limited and Link Investment Trust II of less than five percent shareholding in Intas Pharmaceuticals Limited, a vertically integrated Indian public pharmaceutical company; approval is subject to modifications proposed by the acquirers and the Commission's detailed order will follow. en-us Fri, 01 May 2020 10:03:10 +0530 Fri, 01 May 2020 10:03:10 +0530 TaxTMI RSS Generator https://www.taxtmi.com/news?id=22794 The Competition Commission of India approved under Section 31(1) the acquisition by Canary Investments Limited and Link Investment Trust II of less than five percent shareholding in Intas Pharmaceuticals Limited, a vertically integrated Indian public pharmaceutical company; approval is subject to modifications proposed by the acquirers and the Commission's detailed order will follow. News - Fri, 01 May 2020 10:03:10 +0530 https://www.taxtmi.com/news?id=22794